Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06386679
PHASE1

Amniotic Fluid Mesenchymal Stem Cells Developed for Chondrogenic Treatment (AFCC) Injection in Elderly Knee Osteoarthritis Patients

Sponsor: Siriraj Hospital

View on ClinicalTrials.gov

Summary

Amniotic fluid mesenchymal stem cells developed for chondrogenic treatment (AFCC) are used to treat elderly patients suffering from knee osteoarthritis (OA). The injection reduces inflammation and promotes the recovery of knee function, leading to an improved quality of life.

Official title: A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients

Key Details

Gender

All

Age Range

60 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2023-08-17

Completion Date

2025-03

Last Updated

2024-04-26

Healthy Volunteers

No

Interventions

BIOLOGICAL

allogenic amniotic fluid mesenchymal stem cell

Intra-articular AFCC injection will be given for single knee for each patient in single dose, 20 million of AFCC in each dose

Locations (1)

Siriraj Hospital

Bangkok Noi, Bangkok, Thailand